Home | Business News | Browse by Publication | J | JCN Newswires

Eisai and Quintiles Enter into a Strategic Collaboration to Develop Eisai's Anticancer Compounds.

Publication: JCN Newswires
Publication Date: 30-OCT-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Tokyo, Oct 30, 2009 - (JCN Newswire) - Eisai Co., Ltd. today announced that the company has concluded a strategic collaboration agreement with Quintiles, a world leading biopharmaceutical services company, to develop six anticancer compounds in its oncology pipeline to further expedite its Product Creation Strategy for the oncology-related disease area.

This collaboration is a new business model in which Eisai and Quintiles share clinical development risks and work together to increase speed and probability of success...

Access Full Article, Compliments of Goliath



Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.